Aveo Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-878
| Closed | -$354K | – | 342 |
|
|
2024
Q4 | $354K | Sell |
878
-198
| -18% | -$79.7K | 0.04% | 258 |
|
|
2024
Q3 | $500K | Sell |
1,076
-37
| -3% | -$17.2K | 0.05% | 199 |
|
|
2024
Q2 | $522K | Sell |
1,113
-35
| -3% | -$16.4K | 0.06% | 184 |
|
|
2024
Q1 | $460K | Buy |
1,148
+72
| +7% | +$28.9K | 0.05% | 229 |
|
|
2023
Q4 | $438K | Buy |
1,076
+469
| +77% | +$191K | 0.05% | 220 |
|
|
2023
Q3 | $211K | Sell |
607
-11
| -2% | -$3.83K | 0.03% | 314 |
|
|
2023
Q2 | $217K | Buy |
+618
| New | +$217K | 0.03% | 317 |
|
|
2023
Q1 | – | Sell |
-1,216
| Closed | -$351K | – | 372 |
|
|
2022
Q4 | $351K | Buy |
1,216
+330
| +37% | +$95.3K | 0.05% | 239 |
|
|
2022
Q3 | $257K | Buy |
+886
| New | +$257K | 0.04% | 234 |
|